New York Real Estate Developer, Arthur Becker Is Interviewed On Ideamensch
The first question posed to Arthur Becker during his sit down interview with Ideamensch was where he came up with the idea to create the investment comapny, Madison Partners LLC. Arthur Becker answered that in his last two jobs at Zinio and NaviSite he had delved in quite deeply in the fields of real estate and technology. Arthur Becker decided to pursue real estate as a private venture because he thought there is huge potential in luxury real estate markets. It also allowed him to sit back and relax and not have to worry about running a company on a day to day basis.
Becker says that Madison Partners is not just a real estate investment company. He also invests in various technology companies, especially biotech ones. Becker realized at his previous jobs that technology has huge potential to improve and change people’s lives for the better. He knows that there are great ideas out there that can be invested in and that will make a good return for him. It will also improve people’s lives, which is another side benefit.
Ideamensch then asked Mr. Becker how a standard day for him unfolds and what he tries to do to make it more productive at work. As a private investor with a private investment company, Arthur Becker says his days are very flexible. Becker says he no longer has to worry about attending conferences or working on the phone for hours. Instead, he can focus more on working with the companies he has invested funds in or on property that has invested in. Becker says that he is currently busy with a townhouse development on Sullivan Street in New York City, but is enjoying the challenge that a real estate developer faces in a big city. Meeting challenge head on is a great tactic to make you more productive. You can visit Bloomberg to know more.
Next, Becker was asked about a trend he deems exciting and that has a good future ahead. His answer was that biotech firms are making increasing strides towards cancer treatment. New developments and procedures such as genomic sequencing is making cancer treatment more successful and more personal now. More details can be found on Crunchbase.